Measurement invariance of depression symptom ratings across African American, Hispanic/Latino, and Caucasian adolescent psychiatric inpatients.
Measurement invariance of depression symptom ratings across African American, Hispanic/Latino, and Caucasian adolescent psychiatric inpatients.
复制标题
非裔美国人、西班牙裔/拉丁裔和白种人青少年精神病住院患者抑郁症状评级的测量不变性。
DOI：
10.1037/pas0000708
复制
发表时间：
2019
影响因子：
3.6
通讯作者：
Sharp,Carla
中科院分区：
文献类型：
--
作者：
Mellick,William;Hatkevich,Claire;Venta,Amanda;Hill,RyanM;Kazimi,Iram;Elhai,JonD;Sharp,Carla
贝克抑郁量表II（BDI-II）被广泛用于评估青少年抑郁症状的严重程度。心理测量学调查，包括因素分析研究，与青少年支持BDI-II的可靠性和有效性。然而，这项研究的一个主要局限是样本主要是高加索人/白色人。这是至关重要的，因为抑郁症在不同种族和民族中非常普遍，并且可靠性和发现推广到非高加索人群的程度存在疑问。本研究招募了非裔美国人/黑人（n= 96），西班牙裔/拉丁裔（n= 151），和高加索人/白色（n= 97）青少年精神病住院患者（M年龄= 14.73）测试的测量不变性的BDI-II，使用Osman和同事的双因素解决方案，同时还评估组内的可靠性和并行效度，通过检查与其他症状的措施。在各组中，双因素解决方案，因素负荷和指标阈值是不变的。组内信度估计是足够的，同时效度得到支持。这表明非裔美国人/黑人、西班牙裔/拉丁裔（a）和高加索人/白色青少年住院患者之间的BDI-II症状比较是有效的。这项工作的关键扩展可能包括通过网络分析和不变性测试的抑郁症状评级随着时间的推移，在种族多样的儿童和青少年的抑郁症状集群的潜在不变性检查。
The Beck Depression Inventory–II (BDI-II) is widely used to assess adolescent depressive symptom severity. Psychometric investigations, including factor-analytic studies, with adolescents support the reliability and validity of the BDI-II. However, a major limitation of this research is that samples have been predominantly Caucasian/White. This is critical because depressive illness is highly prevalent across race and ethnicity, and the extent to which reliability and findings generalize to non-Caucasian populations is in question. The present study recruited African American/Black (n= 96), Hispanic/Latino (a)(n= 151), and Caucasian/White (n= 97) adolescent psychiatric inpatients (M age= 14.73) to test the measurement invariance of the BDI-II, using Osman and colleagues’ two-factor solution while also assessing within-group reliability and concurrent validity by examining associations with other symptom measures. Across groups, the two-factor solution, factor loadings, and indicator thresholds were invariant. Within-group reliability estimates were adequate, and the concurrent validity was supported. This suggests BDI-II symptom comparisons between African American/Black, Hispanic/Latino (a), and Caucasian/White adolescent inpatients are valid. Critical extensions of this work may include the examination of potential invariance across depressive symptom clusters via network analysis and invariance testing of depression symptom ratings over time in ethnoracially diverse children and adolescents.